Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).

A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab. 2011 Nov; 104(3):383-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.